Business / Finance

RSS

The growing evidence on standardised packaging of tobacco products

The scientific journal Addiction has today published a collection of peer-reviewed research papers and commentaries that bring together key parts of the evidence base for standardised packaging of tobacco products from 2008 to 2015.

17 Feb 2015

Medics highlight underrepresentation of women in field

Hosted by the Sheffield Women in Medicine Network (SWiM), ‘Building Your Future - SWiM dives in with the Entrepreneurs’, will be a unique opportunity for women to hear personal stories from a diverse group of successful entrepreneurs and share experiences.

17 Feb 2015

POCARED Diagnostics announces closure of another $15M in funding

POCARED Diagnostics Ltd. is an Israeli-based Diagnostics and Pre-analytical technology manufacturer with offices in the United States announced they have closed another $15 Million in funding.

17 Feb 2015

Biotech investor invests in InterCure to increase stake in XTL Biopharmaceuticals

XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, announced today that Israeli biotech investor Alex Rabinovich, its largest shareholder, increased his stake in the Company through his investment in InterCure, an XTL subsidiary, and recent purchases of XTL stock in the market.

17 Feb 2015

CryoLife's revenues increase 5% to $37.2M in fourth quarter 2014

CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today its results for the fourth quarter and full year of 2014.

17 Feb 2015

Celon, Lupin sign definitive agreement to develop generic version of Advair Diskus

Pharma Major Lupin Limited (Lupin) and Celon Pharma S.A. (Celon) announced today that they have entered into a definitive agreement under which the companies will jointly develop a fluticasone/salmeterol dry powder inhaler (DPI) product which is a generic version of GlaxoSmithKline's Advair Diskus®.

17 Feb 2015

Lakeland Pharmacy seeks DAPA certification to pursue government procurement opportunities

Lakeland Pharmacy, a leading full-service pharmacy, pharmaceutical compounding shop, and medical device retailer, announced plans today to expand sales of their home respiratory equipment by applying for a Distribution and Pricing Agreement (DAPA) certification and actively pursuing government procurement opportunities.

17 Feb 2015

Glencoe Software announces completion of Seed Investment Round

Glencoe Software Inc., a world-leader in image data management platforms for the research, biopharma and publication industries, is pleased to announce the completion of its Seed Investment Round, in partnership with TAGS (TIE Angels Group Seattle), several Seattle area angel investors, and Glencoe Friends and Family.

16 Feb 2015

Q'SAI announces formation of new U.S. subsidiary

Celebrating 50 years serving the healthy lifestyles of the Japanese, Q'SAI Co., Ltd., announces the formation of Q'SAI USA Inc., a new United States wholly owned subsidiary that will soon introduce American versions of health products that have become staples in Japan.

16 Feb 2015

Prime Healthcare acquires St. Mary's Medical Center and St. Joseph Medical Center in Missouri

Prime Healthcare announced today that it has completed its acquisition of St. Joseph Medical Center in Kansas City, MO, and St. Mary's Medical Center in Blue Springs, MO, as well as other assets of Carondelet Health from Ascension Health. St. Joseph and St. Mary's medical centers are acute-care hospitals with 456 beds and 900 physicians on staff combined.

14 Feb 2015

DaVita HealthCare Partners announces financial results for fourth quarter 2014

DaVita HealthCare Partners Inc. today announced results for the quarter and year ended December 31, 2014. Income from continuing operations attributable to DaVita HealthCare Partners Inc. for the quarter and year ended December 31, 2014 was $208 million and $723 million, or $0.96 and $3.33 per share, respectively.

13 Feb 2015

Aequitas Capital, Wells Fargo reach financing agreement to support growth of CarePayment

Aequitas Capital announced that it has reached an agreement with Wells Fargo to provide $100 million in additional financing to support the fast-growing demand for CarePayment® and its patient financial engagement programs.

13 Feb 2015

TeamHealth announces acquisition of Ruby Crest Emergency Medicine

TeamHealth Holdings Inc., one of the nation's largest providers of outsourced physician staffing solutions for hospitals, announced the acquisition of the operations of Ruby Crest Emergency Medicine, the group that manages and staffs the hospital emergency department for Northeastern Nevada Regional Hospital in Elko, Nev. Ruby Crest Emergency Medicine's clinicians provide care for approximately 24,000 cases annually.

12 Feb 2015

AMRI optimizes global operations to improve continuous supply chain across its businesses

AMRI today announced that it has implemented several changes to further optimize global business operations in order to enhance continuity from early development through to commercial supply and accelerate the company's global growth objectives.

12 Feb 2015

Hospira announces record fourth-quarter and FY 2014 results

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.

12 Feb 2015

GNC Holdings reports consolidated revenue of $607.2 million for fourth quarter 2014

GNC Holdings, Inc., a leading global specialty retailer of health and wellness products, today reported its financial results for the quarter and year-to-date periods ended December 31, 2014.

12 Feb 2015

Transition Therapeutics commences underwritten public offering of common shares

Transition Therapeutics Inc. announced today that it has commenced an underwritten public offering of its common shares.

12 Feb 2015

SRI Biosciences awarded contract to develop novel polymers to neutralize chemical, biological threats

SRI Biosciences, a division of SRI International, has been awarded a $10 million contract under a DARPA program to reimagine how proteins are constructed and to develop novel medicines and diagnostics as countermeasures to chemical and biological threats.

12 Feb 2015

Resource Ventures announces corporate update, anticipates record annual revenues

Resource Ventures, Inc. Interim President Michael Cipolla is pleased to announce today that the company anticipates reporting record annual revenues.

12 Feb 2015

Epicore BioNetworks named one of 50 strongest companies on TSXV

Epicore BioNetworks Inc. is proud to announce that the Company has been selected by TSX Venture 50 as one of the 50 strongest companies on the TSXV.

12 Feb 2015

Business / Finance

The growing evidence on standardised packaging of tobacco products

Medics highlight underrepresentation of women in field

POCARED Diagnostics announces closure of another $15M in funding

Biotech investor invests in InterCure to increase stake in XTL Biopharmaceuticals

CryoLife's revenues increase 5% to $37.2M in fourth quarter 2014

Celon, Lupin sign definitive agreement to develop generic version of Advair Diskus

Lakeland Pharmacy seeks DAPA certification to pursue government procurement opportunities

Glencoe Software announces completion of Seed Investment Round

Q'SAI announces formation of new U.S. subsidiary

Prime Healthcare acquires St. Mary's Medical Center and St. Joseph Medical Center in Missouri

DaVita HealthCare Partners announces financial results for fourth quarter 2014

Aequitas Capital, Wells Fargo reach financing agreement to support growth of CarePayment

TeamHealth announces acquisition of Ruby Crest Emergency Medicine

AMRI optimizes global operations to improve continuous supply chain across its businesses

Hospira announces record fourth-quarter and FY 2014 results

GNC Holdings reports consolidated revenue of $607.2 million for fourth quarter 2014

Transition Therapeutics commences underwritten public offering of common shares

SRI Biosciences awarded contract to develop novel polymers to neutralize chemical, biological threats

Resource Ventures announces corporate update, anticipates record annual revenues

Epicore BioNetworks named one of 50 strongest companies on TSXV

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News